Serum levels of squamous cell carcinoma antigen and carcinoembryonic antigen as tumor markers of vulvar cancer

Journal of Obstetrics and Gynaecology Research

Volumn 22, Issue 4, 1996, Pages 341-346

  Yamawaki, Takaharu ^a,b   Takeshima, Nobuhiro ^a   Shimizu, Yoshio ^a   Teshima, Hideo ^a   Hasumi, Katsuhiko ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

^b ISE RED CROSS HOSPITAL   (Japan)

Author keywords

CEA; SCC antigen; Vulvar cancer

Indexed keywords

BLEOMYCIN; CARCINOEMBRYONIC ANTIGEN; CISPLATIN; MITOMYCIN C; SQUAMOUS CELL CARCINOMA ANTIGEN; TUMOR MARKER; VINCRISTINE;

ARTICLE; BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; FEMALE; HUMAN; LYMPH NODE METASTASIS; PREOPERATIVE EVALUATION; TUMOR RECURRENCE; TUMOR VOLUME; VULVA CARCINOMA;

EID: 0029801877     PISSN: 13418076     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1447-0756.1996.tb00986.x     Document Type: Article

References (20)

1. Fioretti P, Gadducci A, Ferdeghini M, Prontera C, Malagnino G, Facchini V, Mariani G, Bianchi R. The concomitant determination of different serum tumor markers in epithelial ovarian cancer: Relevance for monitoring the response to chemotherapy and follow-up patients. Gynecol Oncol 1992; 44: 155-160
2. Gadducci A, Ferdeghini M, Prontera C, Moretti L, Mariani G, Bianchi R. The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: Relevance for differential diagnosis. Gynecol Oncol 1992, 44: 147-154
3. Rose PG, Baker S, Fournier L, Nelson BE, Hunter RE. Serum squamous cell carcinoma antigen levels in invasive cervical cancer: Prediction of response and recurrence. Am J Obstet Gynecol 1993; 168: 942-946
4. Kato H, Miyauchi M, Morioka H, Fujino T, Torigoe T. Tumor antigen of human cervical squamous cell carcinoma. Correlation of circulating levels with disease progress. Cancer 1979; 45: 585-590
5. Kato H, Tamai K, Morioka H, Magai M, Nagaya T, Torigoe T. Tumor antigen, TA-4, in the detection of recurrence in cervical squamous cell carcinoma. Cancer 1984; 54: 1544-1546
6. Crombach G, Scharl A, Vierbuchen M, Wurz H, Bolte A. Detection of squamous cell carcinoma antigen in normal squamous epithelia and in squamous cell carcinomas of the uterine cervix. Cancer 1989; 63: 1337-1342
7. Fanning J, Piver, MS. Serial CA125 levels during chemotherapy for metastatic or recurrent endometrial cancer. Obstet Gynecol 1991; 77: 278-280
8. Takeshima N, Shimizu Y, Umezawa S, Hirai Y, Chen J, Fujimoto I, Yamauchi K, Hasumi K. Combined assay of serum levels of CA125 and CA19-9 in endometrial carcinoma. Gynecol Oncol 1994; 54: 321-326
9. DiSaia PJ, Creasman WT. Invasive cancer of the vulva. In: DiSaia PJ, Creasman WT, eds. Clinical Gynecologic Oncology. 3rd ed. St Louis: Mosby, 1989, 241-272
10. Shimizu Y, Hasumi K, Masubuchi K. Effective chemotherapy consisting of bleomycin, vincristine, mitomycin C, and cisplatin (BOMP) for a patient with inoperable vulvar cancer. Gynecol Oncol 1990; 36: 423-427
11. Takeshima N, Nakamura K, Takeda O, Morioka H, Tamura H, Takasugi N, Kato H. Individualization of the cut-off value for serum squamous cell carcinoma antigen using a sensitive enzyme immunoassay. Tumor Biol 1990; 11: 167-172
12. Takeshima N, Nakamura K, Tsuyama S, Kato H. An automated enzyme immunoassay system (IMx) for SCC antigen. J Tumor Marker Oncol 1990; 5: 35-38
13. Neunteufel W, Tatra G, Bieglmayer CH. Serum squamous cell carcinoma antigen levels in women with neoplasms of the lower genital tract and in healthy controls. Arch Gynecol Obstet 1989; 246: 243-250
14. Nam J, Chun K, Chambers JT, Schwartz PE, Cole LA. Urinary gonadotropin fragment, a new tumor marker III. Use in cervical and vulvar cancers. Gynecol Oncol 1990; 38: 66-70
15. Rose PG, Nelson BE, Fournier L, Hunter R. Serum squamous cell carcinoma antigen levels in invasive squamous vulvar cancer. J Surg Oncol 1992; 50: 183-186
16. Pastner B, Mann WJ. Serum squamous cell carcinoma antigen levels in patients with invasive squamous vulvar and vaginal cancer: A preliminary report. Gynecol Oncol 1989; 33: 323-325
17. Sijde R, Bruijn HW, Krans M, Bouma KJ, Aalders JG. Significance of serum SCC antigen as a tumor marker in patients with squamous cell carcinoma of the vulva. Gynecol Oncol 1989; 35: 227-232
18. DiSaia P, Haverback BJ, Dyce BJ, Morrow M. Carcinoembryonic antigen in patients with squamous cell carcinoma of the cervix uteri and vulva. Surg Gynecol Obstet 1974; 138: 542-544
19. DiSaia P, Morrow P, Haverback BJ, Dye BJ. Carcinoembryonic antigen in cervical and vulvar cancer patients. Obstet Gynecol 1976; 47: 95-99
20. Berek JS, Heaps JM, Fu YS, Juillard GJF, Hacker NF. Concurrent cisplatin and 5-fluorouracil chemotherapy and radiation therapy for advanced-stage squamous carcinoma of the vulva. Gynecol Oncol 1991; 42: 197-201